127 related articles for article (PubMed ID: 4007763)
21. Coagulation factor therapy for hemophilia: relation to hepatitis B and to liver function.
Card RT; Dusevic M; Lukie BE
Can Med Assoc J; 1982 Jan; 126(1):34-6. PubMed ID: 7059871
[TBL] [Abstract][Full Text] [Related]
22. Occult hepatitis B virus infection.
Allain JP
Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
[TBL] [Abstract][Full Text] [Related]
23. [Delta hepatitis in Switzerland. Determination of delta antigens and delta antibodies in 397 HBsAg-positive patients (1978-1984)].
Burkhardt F; Schilt U
Schweiz Med Wochenschr; 1984 Jul; 114(30):1042-6. PubMed ID: 6474132
[TBL] [Abstract][Full Text] [Related]
24. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
Fabrizio F; Bunnapradist S; Martin P
J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272
[TBL] [Abstract][Full Text] [Related]
25. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
26. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs.
Loeschke K; Abb J; Farack UM; Wiebecke B
Hepatogastroenterology; 1985 Aug; 32(4):178-80. PubMed ID: 2865200
[TBL] [Abstract][Full Text] [Related]
27. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
[TBL] [Abstract][Full Text] [Related]
28. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
Donataccio D; Roggen F; De Reyck C; Verbaandert C; Bodeus M; Lerut J
Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375
[TBL] [Abstract][Full Text] [Related]
29. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
30. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
[TBL] [Abstract][Full Text] [Related]
31. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
32. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan.
Liu CJ; Lo SC; Kao JH; Tseng PT; Lai MY; Ni YH; Yeh SH; Chen PJ; Chen DS
J Hepatol; 2006 Jan; 44(1):39-46. PubMed ID: 16168517
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization.
Hipgrave DB; Nguyen TV; Vu MH; Hoang TL; Do TD; Tran NT; Jolley D; Maynard JE; Biggs BA
Am J Trop Med Hyg; 2003 Sep; 69(3):288-94. PubMed ID: 14628946
[TBL] [Abstract][Full Text] [Related]
34. Role of delta infection in the progression to chronicity of acute HBsAg positive hepatitis.
Caporaso N; del Vecchio-Blanco C; Servillo F; Suozzo R; Pignalosa G; Manzillo G; Maio G; Izzo CM; Coltorti M
Gastroenterol Clin Biol; 1984; 8(8-9):646-50. PubMed ID: 6489684
[TBL] [Abstract][Full Text] [Related]
35. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C
G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
[TBL] [Abstract][Full Text] [Related]
37. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
Picciotto L; Abrescia N; Ciampi R
Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
[TBL] [Abstract][Full Text] [Related]
38. [Detection of Intrahepatic HBV DNA in HBsAg-negative liver diseases].
Kim YS; Jang JY; Eun SH; Cheon YK; Kim YS; Moon JH; Cho YD; Jin SY; Shim CS; Kim BS
Korean J Hepatol; 2006 Jun; 12(2):201-8. PubMed ID: 16804345
[TBL] [Abstract][Full Text] [Related]
39. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
Datta S; Banerjee A; Chandra PK; Chowdhury A; Chakravarty R
J Med Virol; 2006 Jan; 78(1):53-9. PubMed ID: 16299727
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
